Page last updated: 2024-10-24

response to hypobaric hypoxia

Definition

Target type: biologicalprocess

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension combined with low atmospheric pressure. Hypoxia is defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95% and hypobaric is defined as atmospheric pressure below 0.74 atm (greater than 2,500 m above sea level). [PMID:24590457]

Hypobaric hypoxia, a condition of reduced atmospheric pressure and therefore lower oxygen availability, triggers a complex physiological response in organisms. This response involves multiple systems working in concert to maintain oxygen delivery to tissues and cells.

The initial response to hypobaric hypoxia is detected by chemoreceptors in the carotid and aortic bodies, sensitive to changes in blood oxygen levels (pO2). These receptors send signals to the brainstem, stimulating increased ventilation through the activation of the respiratory center. This leads to deeper and faster breathing, aiming to increase oxygen intake.

Simultaneously, the heart rate and stroke volume increase, driven by the sympathetic nervous system. This increase in cardiac output ensures more efficient oxygen delivery to the tissues.

In the long term, the body adapts to hypobaric hypoxia through various mechanisms. Red blood cell production is stimulated, increasing the oxygen-carrying capacity of the blood. This process, called erythropoiesis, is triggered by the release of erythropoietin, a hormone produced by the kidneys in response to low blood oxygen levels.

Furthermore, the body redistributes blood flow, prioritizing oxygen delivery to vital organs like the brain and heart. This can be achieved through vasoconstriction in non-essential tissues and vasodilation in vital organs.

Another crucial adaptation involves changes in cellular metabolism. In hypoxic conditions, cells switch from aerobic respiration to anaerobic glycolysis, which allows for energy production even in the absence of sufficient oxygen. However, this process is less efficient and produces lactic acid as a byproduct, leading to metabolic acidosis.

Overall, the response to hypobaric hypoxia is a multifaceted process that involves a complex interplay of physiological and cellular mechanisms. These responses aim to maintain adequate oxygen delivery to tissues and cells despite the limited oxygen availability. However, prolonged exposure to hypobaric hypoxia can lead to detrimental effects on the body, potentially leading to hypoxia-induced tissue damage and organ failure.'
```
"

Proteins (1)

ProteinDefinitionTaxonomy
Heat shock factor protein 1A heat shock factor protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q00613]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
zm 336372N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first sourcebenzamides
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
chir-265aromatic ether
az-628AZ-628: a multikinase inhibitor; structure in first sourcebenzamides
GDC-0879indanes;
ketoxime;
primary alcohol;
pyrazoles;
pyridines
antineoplastic agent;
B-Raf inhibitor
plx4032aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
dabrafenib1,3-thiazoles;
aminopyrimidine;
organofluorine compound;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
B-Raf inhibitor
tak-632TAK-632 : A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by (cyclopropanecarbonyl)amino, 4-fluoro-3-{2-[3-(trifluoromethyl)phenyl]acetamido}phenoxy, and cyano groups at positions 2, 6 and 7, respectively. It is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF(V600E), BRAF(WT), respectively.(trifluoromethyl)benzenes;
aromatic ether;
benzothiazoles;
cyclopropylcarboxamide;
monofluorobenzenes;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
necroptosis inhibitor
dinaciclibpyrazolopyrimidine
n2-(1h-indazole-5-yl)-n6-methyl-3-nitropyridine-2,6-diamineKRIBB11 : A member of the class of indazoles that is 1H-indazole substituted by a [6-(methylamino)-3-nitropyridin-2-yl]amino group at position 5. It is an inhibitor of heat shock factor 1 (IC50 = 1.2muM) and suppresses tumour growth in mouse xenograft models.

N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine: a heat shock factor 1 antagonist; structure in first source